Abstract:No. 10716 Conditional survival and functional outcome following surgical treatment for sacral chordoma: a monocentric retrospective review of 115 consecutive cases Tao Ji, Wei Guo, Xiaodong Tang, Yi Yang Musculoskeletal Tumor Center, People’s Hospital, Peking University,Beijing 100044 Background Repeated cohort studies have consistently demonstrate quality of surgical margin at initial surgery is the primary factor to improve survival and local control for patients with sacral chordoma. Conditional survival is a measure of prognosis for patients who have already survived certain period of time; however, data on conditional survival after sacrectomy for patients with sacral chordoma are lacking. Based on current evaluation system, it is difficult to accurately anticipate and detect minor changes in functionality after sacrectomy. Questions/Purposes The purpose of this study is to: (1) determine the conditional survival probability and how effect of prognostic factors changing over time in patients undergoing surgical resection for sacral chordoma; and (2) critical evaluate the postoperative motor, bowel and bladder function by a newly-designed scoring method and clarify the relationship between overall postoperative function and preserved sacral nerve. Patients and Methods One hundred and fifteen patients with sacral chordoma received surgical treatment between Jul 2003 and Dec 2012 were reviewed and the actuarial survival was estimated. The 5-year conditional survival was calculated based on Kaplan-Meier survival analysis. Effect of prognostic factors on conditional survival was also explored. A newly designed score method was proposed and adopted in current study to critically evaluate the function outcome after resection of sacrum. The mean follow-up was 59.3 months (range, 15-130 months). Results The 5-year conditional overall survival decreased with each additional year in the first four years and increased slightly in the fifth year (Fig 1). The 5-year survival decreased from 80.7% at diagnosis to 62.7% at the fourth year and improved to 70.9% at the fifth year. Patients with adequate surgical margin displayed a higher 5-year survival than those with inadequate margin (86.3% versus 67%, p=0.009) at diagnosis and the difference was most significant between the third and fourth year after diagnosis. Conditional survival eatimates for patients received surgeries elsewhere was lower than that of newly diagnosed at baseline (64.1% versus 90.2%, p=0.012) and the survival disadvantage diminished 5 years after diagnosis (66.8% versus 71.1%, p>0.05). The proposed score system for function evaluation well distinguished different level resections. The overall function results for preservation of bilateral S1, S2 and S3 were 39.5%, 60.0% and 81.5% respectively (Fig 2). Preservation of unilateral S3 nerve significantly decreased the incontinence (p=0.01) and sensation (p=0.02) compared with preservation of bilateral S3 nerve roots. Conclusions The 5-year conditional survival for sacral chordoma decreased with each additional year and started to improve since fourth year. Also the impact of surgical margin and previous surgery influencing conditional survival was not

Analysis of Risk Factors for Recurrence after the Resection of Sacral Chordoma Combined with Embolization.

Analysis of Recurrent Factors of Sacral Chordoma

Prognostic Factors of Sacral Chordoma after Surgical Therapy: a Study of 36 Patients.

The clinical outcome of recurrent sacral chordoma with further surgical treatment.

69. Surgical Treatment of Sacral Chordomas with Pre-operative Arterial Embolization and Prognostic Indicators of Outcome

Analysis of Risk Factors for Recurrence of Giant Cell Tumor of the Sacrum and Mobile Spine Combined with Preoperative Embolization

Clinical Outcome after Surgical Treatment of Sacral Chordomas: A Single-Center Retrospective Cohort of 27 Patients

Predictive Value of Preoperative Magnetic Resonance Imaging Findings for Survival and Local Recurrence in Patients Undergoing En Bloc Resection of Sacral Chordomas

Clinical treatment of sacral chordoma

Recurrence or Neurological Loss? Resection Mode Selection for Patients with Large Sacral Chordoma: an Analysis of Prognostic Factors and Quality of Life

Surgical treatment of sacral chordomas combined with transcatheter arterial embolization.

Prognostic Factors in Surgical Patients with Chordomas of the Cervical Spine: A Study of 52 Cases from a Single Institution

Recurrence and Survival Factors Analysis of 171 Cases of Sacral Chordoma in a Single Institute.

Clinical Analysis of Surgical Treatment after Transcatheter Arterial Embolization for Sacral Chor-doma and Its Complications

Abstract No. 10716 Conditional survival and functional outcome following surgical treatment for sacral chordoma: a monocentric retrospective review of 115 consecutive cases

Surgical treatment combined with transcatheter arterial embolization for excision of sacral chordoma

Surgical Management of Sacral Chordoma(A Review of Fifteen Cases)

Survival Analysis of 59 Patients with Sacral Chordomas Treated by Surgery and Radiotherapy

Clinical Characteristics and Predisposing Factors of Lung Metastasis in Sacral Chordoma: a Cross-Sectional Cohort Study of 221 Cases

[The Surgical Management of Sacral Chordoma].

High Expression of Survivin in Sacral Chordoma